Published in Am J Health Syst Pharm on December 15, 2013
A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine. BMC Health Serv Res (2015) 0.75
Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia. Clinicoecon Outcomes Res (2014) 0.75
A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain. Ther Clin Risk Manag (2015) 0.75
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health (2011) 3.88
Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes (2011) 3.25
Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial. J Clin Oncol (2008) 3.16
Patterns and correlates of linkage to appropriate HIV care after HIV diagnosis in the US Medicaid population. Sex Transm Dis (2013) 2.92
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value Health (2011) 2.88
Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res (2012) 2.29
Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med (2009) 2.27
Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health (2005) 1.95
Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc (2002) 1.93
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology (Berl) (2007) 1.92
Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol (2009) 1.88
Patient-reported outcomes: conceptual issues. Value Health (2007) 1.72
Increasing hip fracture incidence in California Hispanics, 1983 to 2000. Osteoporos Int (2004) 1.72
Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology. J Sex Med (2010) 1.53
Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability. Arthritis Care Res (Hoboken) (2011) 1.50
A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture. Menopause (2015) 1.45
Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis. Curr Med Res Opin (2015) 1.43
Anticoagulant use, the prevalence of bridging, and relation to length of stay among hospitalized patients with non-valvular atrial fibrillation. Am J Cardiovasc Drugs (2012) 1.41
Evaluation of the measurement model and clinically important differences for menopause-specific quality of life associated with bazedoxifene/conjugated estrogens. Menopause (2014) 1.39
Considerations on the use of patient-reported outcomes in comparative effectiveness research. J Manag Care Pharm (2011) 1.28
Retrospective study of adherence to glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus in the United States. Adv Ther (2014) 1.22
Estimating a minimally important difference in pulmonary arterial hypertension following treatment with sildenafil. Chest (2008) 1.21
Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care (2004) 1.21
A multi-worksite analysis of the relationships among body mass index, medical utilization, and worker productivity. J Occup Environ Med (2010) 1.20
A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost. Pain Med (2010) 1.17
Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function and work productivity. Arthritis Res Ther (2010) 1.13
Validation of the erection hardness score. J Sex Med (2007) 1.11
The burden associated with neuropathic pain in Western Europe. J Med Econ (2012) 1.09
Preventive services and health behaviors among people with spinal cord injury. J Spinal Cord Med (2005) 1.09
Treatment responsiveness of the Self-Esteem And Relationship questionnaire in erectile dysfunction. Urology (2003) 1.08
Statistical approaches for conducting network meta-analysis in drug development. Pharm Stat (2012) 1.04
Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study. Clin Drug Investig (2011) 1.04
The erection hardness score and its relationship to successful sexual intercourse. J Sex Med (2008) 1.03
Health-related quality of life during treatment for renal cell carcinoma: results from a phase II study of axitinib. Acta Oncol (2008) 0.99
Economic costs of obesity to self-insured employers. J Occup Environ Med (2008) 0.99
Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa. J Oncol Pract (2009) 0.99
Applying quality-of-life data formally and systematically into clinical practice. Mayo Clin Proc (2007) 0.98
Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis. Semin Arthritis Rheum (2013) 0.98
A new approach for interval estimation and hypothesis testing of a certain intraclass correlation coefficient: the generalized variable method. Stat Med (2004) 0.96
Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis. Patient Prefer Adherence (2013) 0.95
Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review. BMJ Open (2013) 0.94
Rationale, objectives and design of the Direct Analysis of Nonvertebral Fracture in the Community Experience (DANCE) study. Osteoporos Int (2005) 0.94
Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes. Clin Trials (2007) 0.94
Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis. BMC Musculoskelet Disord (2010) 0.94
Healthcare utilization and costs of systemic lupus erythematosus in Medicaid. Biomed Res Int (2012) 0.93
Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States. Clin Ther (2013) 0.93
Association between pain severity and health care resource use, health status, productivity and related costs in painful diabetic peripheral neuropathy patients. Pain Med (2011) 0.93
Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis. Am J Cardiol (2008) 0.92
An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study. Curr Med Res Opin (2006) 0.92
Daily process methodology for measuring earlier antidepressant response. Contemp Clin Trials (2008) 0.92
Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis. Expert Opin Pharmacother (2012) 0.92
A systematic review on the application of pharmacoepidemiology in assessing prescription drug-related adverse events in pediatrics. Curr Med Res Opin (2007) 0.91
Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract (2013) 0.91
Changes in health-related quality of life with smoking cessation treatment. Eur J Public Health (2010) 0.91
Burden of fibromyalgia and comparisons with osteoarthritis in the workforce. J Occup Environ Med (2009) 0.91
Anabolic therapies. Curr Osteoporos Rep (2010) 0.90
Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT. Bone (2011) 0.90
Potential health care cost savings associated with early treatment of multiple sclerosis using disease-modifying therapy. Clin Ther (2011) 0.90
Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology. Onco Targets Ther (2012) 0.89
The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome. Sleep Med (2009) 0.88
Direct health care costs of patients with type 2 diabetes within a privately insured employed population, 2000 and 2005. J Occup Environ Med (2009) 0.88
Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts. Eur Orthop Traumatol (2012) 0.88
Healthcare resource utilization and expenditures of women diagnosed with hypoactive sexual desire disorder. J Med Econ (2010) 0.88
Current trends in the surgical management of Dupuytren's disease in Europe: the surgeon's perspective. Eur Orthop Traumatol (2012) 0.87
Association between prescription cost sharing and adherence to initial combination antiretroviral therapy in commercially insured antiretroviral-naïve patients with HIV. J Manag Care Pharm (2012) 0.86
Perioperative myocardial ischemic injury in high-risk vascular surgery patients: incidence and clinical significance in a prospective clinical trial. J Vasc Surg (2006) 0.86
Increased Cause-specific Mortality in Patients with Mild and Severe Psoriasis: A Population-based Swedish Register Study. Acta Derm Venereol (2015) 0.86
Dupuytren's contracture: a retrospective database analysis to determine hospitalizations in the Netherlands. BMC Res Notes (2011) 0.86
Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study. Clin Ther (2012) 0.85
Application of the Itch Severity Score in patients with moderate-to-severe plaque psoriasis: Clinically important difference and responder analyses. J Dermatolog Treat (2014) 0.85
Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study. BMC Neurol (2011) 0.85
Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis. J Med Econ (2015) 0.85
The association of sleep difficulties with health-related quality of life among patients with fibromyalgia. BMC Musculoskelet Disord (2012) 0.84
Primary nonadherence to medications in an integrated healthcare setting. Am J Manag Care (2012) 0.84
Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: Results from an international, multi-center, double-blind, placebo-controlled trial. J Sex Med (2006) 0.83
Evaluating the sexual experience in men: validation of the sexual experience questionnaire. J Sex Med (2007) 0.83
Methodological considerations in using claims databases to evaluate persistence with bisphosphonates for osteoporosis. Curr Med Res Opin (2007) 0.83
Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates. South Med J (2009) 0.82
Regulatory issues for health-related quality of life--PhRMA Health Outcomes Committee workshop, 1999. Value Health (2002) 0.82
Fractures in women treated with raloxifene or alendronate: a retrospective database analysis. BMC Womens Health (2013) 0.82
Commentary: the five Ws of a Fracture Liaison Service: why, who, what, where, and how? In osteoporosis, we reap what we sow. Curr Osteoporos Rep (2013) 0.82
Venous thromboembolism in the US: does race matter? J Thromb Thrombolysis (2011) 0.82
Sexual function questionnaire: further refinement and validation. J Sex Med (2012) 0.82
Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate. Ann Pharmacother (2009) 0.82
Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-Analyses. Dermatol Ther (Heidelb) (2012) 0.81
Self-esteem, confidence, and relationships in men treated with sildenafil citrate for erectile dysfunction: results of two double-blind, placebo-controlled trials. J Gen Intern Med (2006) 0.81
Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg (2008) 0.81
Using the Rasch model to validate and enhance the interpretation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index--Disease-Related Symptoms scale. Value Health (2008) 0.81
Redefining osteoporosis treatment: Who to treat and how long to treat. Arq Bras Endocrinol Metabol (2006) 0.81
Herpes zoster-attributable resource utilization and cost burden in patients with solid organ transplant. Transplantation (2014) 0.81
Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay. Am J Health Syst Pharm (2012) 0.81
Interpreting effect sizes and clinical relevance of pharmacological interventions for fibromyalgia. Pain Ther (2013) 0.80
Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting. J Dermatolog Treat (2013) 0.80
Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine. Pain Pract (2011) 0.80
Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma. J Cancer Surviv (2011) 0.80
Employees' willingness to pay to prevent influenza. Am J Manag Care (2010) 0.80